Back
Cochlear Vs. Kazia Therapeutics Industry Stock Comparison
Buy
67
CHEOF
Cochlear
Last Price:
216.00
Seasonality Move:
2.4%
Sell
32
KZIA
Kazia Therapeutics
Last Price:
0.29
Seasonality Move:
-13.74%
Buy
67
Cochlear (CHEOF)
is a Buy
Is Cochlear a Buy, Sell or Hold?
- The current Cochlear [CHEOF] share price is $216.00. The Score for CHEOF is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- CHEOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Kazia Therapeutics (KZIA)
is a Sell
Is Kazia Therapeutics a Buy, Sell or Hold?
- The current Kazia Therapeutics [KZIA] share price is $0.29. The Score for KZIA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- KZIA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CHEOF Stock Price Chart
KZIA Stock Price Chart
What is Kazia Therapeutics's stock price today?
-
The Kazia Therapeutics share price today is $0.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KZIA is experiencing buying pressure, which is a positive indicator for future bullish movement.
CHEOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 56.48 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (206.79 - 214.37) | Buy |
| Bollinger Bands (100): | (198.72 - 221.32) | Buy |
KZIA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 42.03 | Sell |
| Chaikin Money Flow: | 7964 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.3 - 0.4) | Sell |
| Bollinger Bands (100): | (0.26 - 0.38) | Sell |
CHEOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 211 | Buy |
| 20-day SMA: | 209.8 | Buy |
| 50-day SMA: | 217.42 | Sell |
| 200-day SMA: | 188 | Buy |
| 8-day EMA: | 212.4 | Buy |
| 20-day EMA: | 211.84 | Buy |
| 50-day EMA: | 212.54 | Buy |
| 200-day EMA: | 193.46 | Buy |
KZIA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.29 | Sell |
| 20-day SMA: | 0.33 | Sell |
| 50-day SMA: | 0.3 | Sell |
| 200-day SMA: | 0.56 | Sell |
| 8-day EMA: | 0.3 | Sell |
| 20-day EMA: | 0.32 | Sell |
| 50-day EMA: | 0.32 | Sell |
| 200-day EMA: | 0.59 | Sell |
Cochlear Earnings Growth & CHEOF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kazia Therapeutics Earnings Growth & KZIA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.01 per share.
Cochlear Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kazia Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||